Systemic radiopharmaceutical therapy of painful osteoblastic metastases
References (48)
Unsealed source therapy of painful bone metastases
Semin Nucl Med
(1997)- et al.
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer
Int J Radiat Oncol Biol Phys
(1993) - et al.
Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases
Semin Nucl Med
(1992) 153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals
Nucl Med Biol
(1987)- et al.
A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer
Radiother Oncol
(1994) - et al.
Painful bone metastases in hormone-refractory prostate cancer: Economic costs of strontium-89 and/or external radiotherapy
Urology
(1997) - et al.
153Sm radiotherapeutic bone agents
Nucl Med Biol
(1986) - et al.
A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphate (EDTMP) in the treatment of patients with painful bone metastases
Eur J Cancer
(1997) - et al.
Samarium-153-labeled EDTMP for bone metastases from cancer of the prostate
Clin Oncol
(1992) - et al.
Preparation of rhenium-186 labeled HEDP and its possible use in the treatment of osseous neoplasms
Int J Appl Rad Isotopes
(1979)
The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine
Nucl Med Biol
(1986)
Bone destruction in cancer
Semin Oncol 20
(1993)
World Health Organization, Geneva, Switzerland
(1990)
Radiopharmaceuticals for bone malignancy
J Nucl Med Technol
(1998)
Palliation therapy with bone seeking radiopharmaceuticals
Cancer Biother Radiopharm
(1998)
Radiopharmaceuticals for palliation of metastatic osseous lesions: Biologic and physical background
Semin Nucl Med
(1992)
Selective accumulation of strontium-89 in metastatic deposits in bone; Radiohistological correlation
Nucl Med Commun
(1995)
Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate
Eur J Nucl Med
(1986)
Radiation dose calculations in persons receiving injections of samarium-153 EDTMP
J Nucl Med
(1987)
Tin-117m(4+) DTPA: Pharmacokinetics and imaging characteristics in patients with metastatic bone pain
J Nucl Med
(1997)
Samarium-153-EDTMP biodistribution and dosimetry estimation
J Nucl Med
(1993)
A Monte Carlo simulation model for radiation dose to metastatic skeletal tumor from rhenium-186(Sn)-HEDP
J Nucl Med
(1995)
Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer
Eur J Nucl Med
(1994)
Efficacy of rhenium-186 etidronate in prostate cancer patients with metastatic bone pain
J Nucl Med
(1996)
Cited by (0)
Copyright © 2000 W.B. Saunders Company. All rights reserved. Published by Elsevier Inc. All rights reserved.